Hello, everyone, and how are you today? Cloudy skies are hovering over the Pharmalot corporate campus, where the short people are hustling off to their school houses for a new year of learning. Meanwhile, we are attacking the middle-of-the-week syndrome, which is another way of saying there is much to do. And yes, we are fortifying ourselves with a cup of stimulation. As always, you are free to join us. And as usual, here are some tidbits to help you get started on your own busy routine. Hope your day goes well and let us know if you hear anything interesting...
Roche Commits To Maintain R&D Spending Levels (Dow Jones)
Pfizer Wins FDA Approval For Leukemia Drug (Bloomberg News)
Pfizer Gets EC Approval For Kidney Cancer Drug (Dow Jones)
Chinese Firm Sued By SEC Over Phony Weight-Loss Product (Bloomberg News)
IFPMA Codes Emphasizes Research Benefits (Outsourcing Pharma)
Glaxo Studies Three-In-One Emphysema Med (Bloomberg News)
EDITOR'S NOTE: Please check this post for updates during the day